Effects of topiramate and valproate acid on serum insulin and leptin levels in young and adult rats

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 3, 2007, Pages 229-232

  Li, Jing ^a   Li, Dan ^a   Huang, Shao Ping ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Insulin; Leptin; Rats; Topiramate; Valproic acid

Indexed keywords

INSULIN; LEPTIN; SODIUM CHLORIDE; TOPIRAMATE; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; NONHUMAN; RADIOIMMUNOASSAY; RAT;

AGE FACTORS; ANIMALS; ANTICONVULSANTS; BODY WEIGHT; FEMALE; FRUCTOSE; INSULIN; LEPTIN; RATS; RATS, SPRAGUE-DAWLEY; VALPROIC ACID;

EID: 34250678505     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yin L, Peng XS, Xi WW, Demarest K. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment[J]. Metabolism, 2006, 55(10): 1411-1419.
2. Frigerio F, Chaffard G, Berwaer M, Maechler P. The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate[J]. Biochem Pharmacol, 2006, 72(8): 965-973.
3. Lalonde J, Samson P, Poulin S, Deshaies Y, Richard D. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ ob mice [J]. Physiol Behav, 2004, 80(4):415-420.
4. Rechard D, Picard F, Lemieux C, Lalonde J, Samson P, Deshaies Y. The effects of topiramate and sex hormones on energy balance of male and female rats[J]. Int J Obes Relat Metab Disord, 2002, 26 (3):344-353.
5. Luef GJ, Lechleitner M, Bauer G, Trinka E, Hengster P. Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients [J]. Epilep Res, 2003, 55(1-2): 53-58.
6. Jallon P, Pecard F. Body weight gain and anticonvulsants: a comparative review[J]. Drug Saf, 2001, 24(13):969-978.
7. Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, et al. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women[J]: J Neurol, 2002, 249(7):835-841.
8. York DA, Singer L, Thomas S. Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncouping-protein mRNAs[J]. Nutrition, 2000, 16(10):967-975.
9. Richard D, Ferland J, Lalonda J, Samson P, Deshaies Y. Influence of topiramate in the regulation of energy balance [J]. Nutrition, 2000, 16(10):961-966.
10. Pecard F, Deshaies Y, Lalonde J. Topiramate reduces energy and fat gains in lean and obese (fa/fa) zucker rats [J]. Obes Res, 2000, 8(9):656-663.
11. Oscar Gó mez, Esther Ruiz, Paula Vieitez, Olga Gonzalez-Albarran, Juana Fraile, Jose M. Sancho, Rafael Garcí a-Robles. Preliminary results of topiramate in an experimental model of obesity, insulin resistance and hypertension (obese Zucker rats) [J]. Am J Hypertens, 2002, 15(4): 192-196.
12. Elaine C, Wirrell EC. Valproic acid-associated weight gain in older children and teens with epilepsy [J]. Pediatr Neurol, 2003, 28 (2): 126-129.
13. Pylvänen V, Pakarinen A, Knip M, Isojärvi J. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy[J]. Epilep Behav, 2006, 8(3): 643-648.
14. Pylvanen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojarvi JI. Serum insulin and leptin levels in valproate-associated obesity [J]. Epilepsia, 2002, 43(5):514-517.
15. Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F. Insulin resistance in epileptic girls who gain weight after therapy with valproic acid [J]. J Child Neurol, 2002, 17(4): 265-268.
16. Isojavi JI, Tauboll E, Pakarinen AJ, van Parys J, Rattya J, Harbo HF, et al. Alterd ovarian function and cardiovascular risk factors in valproate treated women[J]. Am J Med, 2001, 111(4):290-296.